TITLE:
Cervical Pregnancy in a Primigravida Patient without Risk Factors: A Case Report
AUTHORS:
Dieudonné Sengeyi Mushengezi Amani, Eloge Ilunga-Mbaya, Francis Ebola Iyawa, Berry Kinkenda Nsiangangu
KEYWORDS:
Cervical Pregnancy, Risk Factors, Hemorrhage, Methotrexate
JOURNAL NAME:
Open Journal of Obstetrics and Gynecology,
Vol.10 No.6,
June
11,
2020
ABSTRACT: Cervical pregnancy is
defined as the implantation of the egg below of the internal cervical orifice,
and remains a rare clinical entity which affects on average 1 out of 20,000 pregnancies
worldwide. Its hemorrhagic
complications are life-threatening in case of late diagnosis. It occurs mainly
on a history of curettage or caesarian which are the most recognized risk
factors. The objective pursued
here is to discuss the possibility of the occurrence of this rare clinical
entity in a primigravida without risk factors and the different therapeutic
possibilities according to the technical platforms. Authors report a case of cervical pregnancy at 6
weeks’ gestation occurring in
a primigravida without risk factors who consulted at University clinics of
Kinshasa (UCK) for a genital hemorrhage chart. The diagnosis was made using
ultrasound and treatment provided by curettage followed by the placement of an
intra-cervical foley tube for hemostatic purposes. Given its high mortality, the diagnosis must be
early even in pregnant women without obvious risk factors. The diversity of
therapeutic means gives practitioners a choice depending on the technical
platform.